{"id":"W3088624338","doi":"10.1093/ibd/izaa236","title":"Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies","year":2020,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Janssen Research and Development; Janssen Scientific Affairs; AbbVie; AstraZeneca; Amgen","keywords":"Ustekinumab; Medicine; Adverse effect; Internal medicine; Hazard ratio; Inflammatory bowel disease; Placebo; Crohn's disease; Psoriasis; Ulcerative colitis; Gastroenterology; Confidence interval; Dermatology; Disease; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069176,0.002153591,0.007235773,0.005618678,0.0003136323,0.002703173,0.001108353,0.001486569,0.002844104],"category_scores_gemma":[0.06444717,0.0009612495,0.03343729,0.004590267,0.0006629005,0.001392354,0.001691023,0.001299606,0.0003638047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005382,"about_ca_system_score_gemma":0.001609769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007045832,"about_ca_topic_score_gemma":0.001048632,"domain_scores_codex":[0.9513088,0.03013465,0.008805214,0.003080661,0.00608578,0.0005849259],"domain_scores_gemma":[0.9269065,0.03882279,0.02317985,0.005180161,0.005383534,0.0005271355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.05563808,0.0001732816,0.03031829,0.03404058,0.816573,0.0001103693,0.0001461119,0.003316626,0.00145476,0.0002576116,0.002151534,0.05581967],"study_design_scores_gemma":[0.01671226,0.006764814,0.07403287,0.004413997,0.8848451,0.0003545095,0.0001044041,0.002363207,0.001716294,0.001501735,0.007060212,0.0001306508],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2090884,0.7238973,0.03126769,0.001168544,0.0009070717,0.005712968,0.02074548,0.0006351911,0.006577282],"genre_scores_gemma":[0.9078261,0.06641245,0.00871365,0.001189173,0.0007550494,0.005588746,0.008450212,0.0001953317,0.0008692638],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.069176,"threshold_uncertainty_score":0.365842,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0135605247310016,"score_gpt":0.2703856700215992,"score_spread":0.2568251452905976,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}